173
Participants
Start Date
January 31, 2014
Primary Completion Date
September 30, 2014
Study Completion Date
December 31, 2014
Daclatasvir
Sofosbuvir
North Shore University Hospital, Manhasset
Premier Medical Group Of The Hudson Valley, Pc, Poughkeepsie
Center For Liver Diseases, Pittsburgh
Main Line Gastroenterology Associates Pc, Perkasie
Mercy Medical Center, Inc., Baltimore
Digestive Disease Associates, P.A., Baltimore
Inova Fairfax Hospital, Falls Church
Digestive Health Specialists, PA, Winston-Salem
Asheville Gastroenterology Associates, PA, Asheville
Gastrointestinal Specialists Of Georgia, Marietta
Atlanta Gastroenterology Associates, Atlanta
University of Florida Hepatology Research, Gainesville
Midland Florida Clinical Research Center, LLC, DeLand
Gastro One, Germantown
Dupage Medical Group, Downers Grove
Kansas City Research Institute, Kansas City
Texas Clinical Research Institute, LLC, Arlington
American Research Corporation, San Antonio
Lifetree Clinical Research, Salt Lake City
Clinical Research Centers Of America, Murray
Southwest Care Center, Santa Fe
Peter J Ruane MD Inc, Los Angeles
National Research Institute, Los Angeles
Anthony M. Mills MD Inc, Los Angeles
Huntington Medical Research Institutes, Pasadena
Scripps Clinic, La Jolla
Precision Research Institute, LLC, San Diego
Medical Associates Research Group, San Diego
Quest Clinical Research, San Francisco
Virginia Mason Medical Center, Seattle
Fundacion De Investigacion De Diego, San Juan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY